LymphedemaV1, Main, Merge, indexHead, Idat.i

Index : Idat.i

Les termes de plus forte occurence

4	0732-183X:2008:Mclaughlin S:prevalence:of:lymphedema
4	0425-1644:2007:Van Brantegem L:antibodies:to:elastin
4	0360-3016:1986:Pezner R:arm:lymphedema:in
4	0267-0623:1981:Gore S:assessing:clinical:trials
4	0093-0415:2001:Avery R:immigrant:women:s
4	0035-9203:2002:Nielsen N:lymphatic:filariasis:specific
4	0024-7766:1983:Rada I:lympho:nodal:fibrosclerosis
4	0004-8380:1992:Casley Smith J:modern:treatment:of
3	1876-4983:2010:Stuart W:letter:from:the
3	1460-2725:2003:Moffatt C:lymphoedema:an:underestimated
3	1460-2725:2002:Siems W:oxidative:stress:in
3	1034-4810:1997:Paradisis M:yellow:nail:syndrome
3	0964-6906:1998:Ferrell R:hereditary:lymphedema:evidence
3	0962-1067:1995:Logan V:incidence:and:prevalence
3	0959-8049:1998:Karlsson P:soft:tissue:sarcoma
3	0959-4493:2004:Bensignor E:p:treatment:of
3	0941-1291:1995:Kinjo O:lymphatic:vessel:to
3	0937-4477:1995:Ichimura K:essentials:of:surgical
3	0923-7534:1998:Dini D:the:role:of
3	0885-3924:1996:Newman M:lymphedema:complicated:by
3	0885-3924:1994:Farncombe M:lymphedema:the:seemingly
3	0885-3924:1993:Passik S:psychiatric:consultation:for
3	0885-3924:1992:Brennan M:lymphedema:following:the
3	0803-5253:2001:Fatinni Y:possible:new:autosomal
3	0749-2081:2001:Nail L:long:term:persistence
3	0749-2081:2000:Hull M:lymphedema:in:women
3	0748-7983:1998:Ridings P:modern:trends:in
3	0748-7983:1996:Bhargava A:localized:neurofibromatosis:associated
3	0748-7983:1995:Janse A:lymphedema:induced:lymphangiosarcoma
3	0741-5214:1995:Allen P:lower:extremity:lymphedema
3	0738-1085:2002:Campisi C:lymphedema:and:microsurgery
3	0738-1085:1998:Campisi C:frontiers:in:lymphatic
3	0736-8046:1987:Magid M:the:yellow:nail
3	0730-725X:1992:Case T:magnetic:resonance:imaging
3	0340-6997:1985:Kleinhans E:evaluation:of:transport
3	0340-6199:1986:Mucke J:early:onset:lymphoedema
3	0309-0167:1995:Huguet P:cutaneous:verruciform:xanthoma
3	0309-0167:1995:Fukunaga M:endovascular:papillary:angioendothelioma
3	0307-6938:1996:Sabroe R:facial:granulomatous:lymphoedema
3	0307-6938:1993:Offori T:angiosarcoma:in:congenital
3	0307-6938:1992:Wilkinson S:toxic:epidermal:necrolysis
3	0307-6938:1987:Mayou S:deep:subcutaneous:dermatophyte
3	0305-4179:1998:Anand S:lymphedema:of:the
3	0305-4179:1995:Balakrishnan C:burns:of:the
3	0305-4179:1994:Balakrishnan C:lymphoedema:of:lower
3	0303-6987:2001:Murphy M:granulomatous:lymphangitis:of
3	0300-9130:1992:Knight K:coumarins:macrophage:proteinase
3	0300-9130:1986:Piller N:the:effect:of
3	0300-5771:2001:Dissanayake S:in:wuchereria:bancrofti
3	0266-7681:1992:Morgan R:complex:physical:therapy
3	0197-3851:2002:Souka A:congenital:lymphedema:presenting
3	0190-9622:1997:Anzilotti M:xanthomatosis:associated:with
3	0190-9622:1993:Bull R:abnormal:lymph:drainage
3	0190-9622:1992:Snider R:verruciform:xanthomas:and
3	0190-9622:1986:Leshin B:lymphangioma:circumscriptum:following
3	0190-9622:1985:Reed B:lymphedema:of:the
3	0190-9622:1984:Venencie P:yellow:nail:syndrome
3	0190-9622:1984:Pavlidakey G:yellow:nail:syndrome
3	0168-9525:2000:Robertson S:rtk:mutations:and
3	0167-6806:1996:Djavanmard M:impaired:hemorheology:in
3	0167-6806:1996:Cornish B:bioelectrical:impedance:for
3	0167-6806:1989:Mcguire W:pain:control:in
3	0161-6420:2000:Bernardini F:chronic:eyelid:lymphedema
3	0148-7299:2001:Mansour S:incontinentia:pigmenti:in
3	0148-7299:2001:Holberg C:segregation:analyses:and
3	0148-7299:2000:Jacquemont S:familial:congenital:pulmonary
3	0148-7299:2000:Amor D:polymicrogyria:associated:with
3	0148-7299:1999:Limwongse C:microcephaly:lymphedema:chorioretinal
3	0148-7299:1998:Strenge S:microcephaly:lymphedema:syndrome
3	0148-7299:1997:Angle B:expansion:of:the
3	0142-2782:1998:Hawley A:the:effect:of
3	0141-8955:1994:Chabas A:mild:phenotypic:expression
3	0140-6736:1996:Katchan B:hypercalcaemia:with:lymphoedema
3	0140-6736:1993:Bull R:pretibial:myxoedema:a
3	0140-6736:1991:Braude S:lymphoedema:hypercalcaemia:syndrome
3	0091-2751:1998:Kapoor A:hypoechoic:periportal:cuffing
3	0049-0172:1993:Mulherin D:lymphedema:of:the
3	0049-0172:1993:Joos E:lymphatic:disorders:in
3	0035-9203:1988:De Lalla F:endemic:non:filarial
3	0032-5473:1997:Hershko A:yellow:nail:syndrome
3	0025-6196:1997:Howarth D:increased:lymphoscintigraphic:flow
3	0022-5347:1998:Ross J:primary:lymphedema:of
3	0022-5347:1997:Mor Y:granulomatous:lymphangitis:of
3	0022-5347:1996:Steinberg J:a:surgical:approach
3	0022-4804:2001:Kosir M:surgical:outcomes:after
3	0022-4790:2000:Majeski J:cutaneous:angiosarcoma:in
3	0022-4790:2000:Grobmyer S:role:of:surgery
3	0022-4790:1990:Scanlon E:sodium:studies:in
3	0022-4790:1985:Bartal A:malignant:melanoma:appearing
3	0022-4790:1984:Zanolla R:evaluation:of:the
3	0022-3476:1997:Harel L:lymphedema:praecox:seen
3	0022-3476:1992:Potter C:primary:and:secondary
3	0022-3468:1989:Levine C:primary:disorders:of
3	0022-2593:1997:Morris A:parent:child:transmission
3	0022-2593:1987:Dale R:primary:lymphoedema:when
3	0022-2593:1985:Dale R:the:inheritance:of
3	0022-1899:1993:Lammie P:heterogeneity:in:filarial
3	0011-9059:2003:Ogawa M:lymphoscintigraphic:analysis:in
3	0011-9059:1997:Araujo J:effective:management:of
3	0011-9059:1992:Ohkuma M:lymphedema:treated:by
3	0011-9059:1986:Knuckles M:yellow:nail:syndrome
3	0009-9260:1995:Collins C:computed:tomography:in
3	0009-9260:1991:Svensson W:the:use:of
3	0009-9260:1990:Vaughan B:ct:of:swollen
3	0009-9260:1984:Mcivor J:lymphatic:hypoplasia:without
3	0009-9163:2002:Bahuau M:foxc:truncating:mutation
3	0009-9163:1995:Fryns J:on:the:nosology
3	0009-9163:1987:Treisman J:adult:turner:syndrome
3	0009-9163:1985:Leung A:dominantly:inherited:syndrome
3	0007-1323:1992:Hoe A:incidence:of:arm
3	0007-1323:1985:Hurst P:long:term:results
3	0007-1226:1990:O Brien B:microsurgical:transfer:of
3	0007-1226:1990:Chen H:lymph:node:transfer
3	0007-1226:1988:Ho L:microlymphatic:bypass:in
3	0007-1226:1988:Chen H:the:use:of
3	0007-1226:1985:Maisels D:lymphoedema:of:the
3	0007-1161:1986:Perry H:chronic:lymphangiectasis:in
3	0007-0963:2002:Karg E:primary:lymphoedema:associated
3	0007-0963:2000:Schwartz R:penile:kaposi:s
3	0007-0963:2000:Rosbotham J:distichiasis:lymphoedema:clinical
3	0007-0963:2000:Hengge U:acquired:immune:deficiency
3	0007-0963:2000:Bohm M:bilateral:upper:limb
3	0007-0963:1997:Mallon E:evidence:for:altered
3	0007-0963:1997:Lister R:squamous:cell:carcinoma
3	0007-0963:1996:Cox N:a:reticulate:vascular
3	0007-0963:1996:Bull R:lymphatic:function:in
3	0007-0963:1994:Auriol F:study:of:cutaneous
3	0007-0963:1993:Hills R:cutaneous:secondary:follicular
3	0007-0963:1985:Tatnall F:non:hodgkin:s
3	0007-0963:1984:Partsch H:the:dermal:lymphatics
3	0007-0912:2003:Mallick A:disorders:of:the
3	0003-9993:1996:Brennan M:focused:review:postmastectomy
3	0003-9888:1994:Wright N:the:swollen:leg
3	0003-4975:1999:Dagenais F:spontaneous:chylothorax:associated
3	0003-4967:1990:Dacre J:lymphoedema:of:the
3	0002-9610:1999:Velanovich V:quality:of:life
3	0002-9610:1999:Ramos S:edema:volume:not
3	0002-9610:1984:Miller T:surgical:approach:to
3	0002-9343:2000:Szuba A:decongestive:lymphatic:therapy
3	0002-9297:2000:Irrthum A:congenital:hereditary:lymphedema
3	0002-9297:2000:Bull L:mapping:of:the
3	0002-9297:1999:Mangion J:a:gene:for
3	0002-9297:1999:Evans A:mapping:of:primary
3	0002-9270:1998:Halm U:primary:amyloidosis:of
3	0001-706X:1999:Olszewski W:bacteriological:studies:of
3	0001-6268:1978:Levander B:lumbo:omental:shunt
3	0001-2998:1993:Mandell G:a:multiscintigraphic:approach
2	8756-0437:1985:Abbott W:the:omentum:in
2	8755-6863:1998:Sacco O:yellow:nail:syndrome
2	8755-1039:2002:Mohanty S:microfilaria:in:thyroid
2	8750-7587:2007:Lane K:upper:extremity:lymphatic
2	1863-2297:2012:Babu S:immunopathogenesis:of:lymphatic
2	1748-6815:2007:Cichowitz A:erysipelas:like:inflammation
2	1610-0379:2004:Pavlotsky F:recurrent:erysipelas:risk
2	1567-1348:2007:Hoti S:polymorphism:of:gp
2	1552-4825:2012:Hazan F:a:novel:kif
2	1552-4825:2011:Ferguson J:primary:lymphedema:with
2	1552-4825:2010:Tanpaiboon P:c:insc:of
2	1552-4825:2010:O Driscoll M:agenesis:of:the
2	1552-4825:2010:Mansour S:emberger:syndrome:primary
2	1552-4825:2010:Child A:lipedema:an:inherited
2	1552-4825:2007:Yabuki S:spinal:extradural:arachnoid
2	1552-4825:2007:Van Steensel M:lymphedema:cardiac:septal
2	1551-7144:2009:Schmitz K:physical:activity:and
2	1531-0035:2009:Bunke N:phlebolymphemeda:usually:unrecognized
2	1523-6161:2003:Taneja S:a:multidisciplinary:approach
2	1522-1946:2000:Tsang H:cutaneous:oozing:of
2	1475-0961:2012:Jensen M:validity:and:interobserver
2	1475-0961:2012:Jensen M:the:washout:rate
2	1475-0961:2010:Mayrovitz H:male:female:differences
2	1475-0961:2010:Jensen M:lymphoedema:of:the
2	1475-0961:2009:Mayrovitz H:suitability:of:single
2	1475-0961:2008:Mayrovitz H:local:tissue:water
2	1475-0961:2007:Gebruers N:volumetric:evaluation:of
2	1472-6483:2001:Brugo Olmedo S:definition:and:causes
2	1471-4922:2006:Michael E:mathematical:models:and
2	1471-4922:2003:Ravindran B:aping:jane:goodall
2	1471-4922:2001:Hoerauf A:call:to:consolidate
2	1471-4914:2001:Karkkainen M:molecular:regulation:of
2	1466-4879:2003:Hise A:polymorphisms:of:innate
2	1460-2725:2004:Moffatt C:prevalence:of:leg
2	1445-1433:2007:Poole M:pr:what:i
2	1445-1433:2003:Serpell J:radical:lymph:node
2	1445-1433:2001:Halder A:rising:incidence:of
2	1386-0291:2000:Casley Smith J:changes:in:the
2	1368-8375:2007:Raguse J:lower:extremity:lymphedema
2	1368-5031:2003:Vereecken P:spread:of:melanoma
2	1368-5031:2002:Sparaco A:arm:lymphoedema:following
2	1360-2276:2008:Tekola F:development:and:testing
2	1360-2276:2006:Tekola F:economic:costs:of
2	1360-2276:2006:Dreyer G:interdigital:skin:lesions
2	1360-2276:2006:Babu B:impact:of:chronic
2	1360-2276:2005:Kerketta A:a:randomized:clinical
2	1359-2998:1999:Fischler B:cytomegalovirus:dna:detection
2	1359-2998:1996:Boyd P:antenatal:diagnosis:of
2	1358-863X:1998:Szuba A:lymphedema:classification:diagnosis
2	1358-863X:1998:Stanton A:forearm:blood:flow
2	1358-2267:2003:Kessler T:effect:of:manual
2	1357-6321:2005:Howell D:evaluation:of:a
2	1286-4579:1999:De Almeida A:epidemiology:and:immunopathology
2	1198-0052:2017:Segal R:exercise:for:people
2	1153-2424:1994:Gaisne E:anatomie:du:systeme
2	1102-4151:1994:Nagata Y:intraarterial:infusion:of
2	1099-8004:2008:Knobf M:an:aerobic:weight
2	1079-2104:1997:Sollecito T:elephantiasis:nostras:of
2	1078-5884:1995:Haaverstad R:venous:haemodynamics:and
2	1078-5884:1995:Haaverstad R:lymph:drainage:and
2	1078-0432:2012:Finegold D:connexin:mutations:increase
2	1076-6332:1995:Witte C:disorders:of:lymph
2	1076-0512:2002:Furukawa H:squamous:cell:carcinoma
2	1076-0512:1998:Christian M:metastatic:basal:cell
2	1072-7515:2011:Cemal Y:preventative:measures:for
2	1072-7515:2002:Lawton G:preservation:of:muscle
2	1072-7515:2001:Sener S:the:spectrum:of
2	1072-7515:1997:Reece G:lower:extremity:salvage
2	1068-9265:1995:Dawson W:elective:hand:surgery
2	1068-9265:1994:Brady M:post:treatment:sarcoma
2	1066-2936:1994:Daugherty C:unexplained:muscle:swelling
2	1061-4036:2000:Karkkainen M:missense:mutations:interfere
2	1058-4838:2012:Mand S:doxycycline:improves:filarial
2	1058-4838:1996:Moore T:diethylcarbamazine:induced:reversal
2	1055-9965:2010:Norman S:risk:factors:for
2	1055-9965:2007:Paskett E:the:epidemiology:of
2	1051-2276:1999:Di Iorio B:bioelectrical:impedance:measurement
2	1043-3074:2012:Maus E:near:infrared:fluorescence
2	1041-2972:2001:Kemp C:infectious:diseases:filariasis
2	1038-5282:1999:Mcgrath P:a:study:of
2	1018-8665:2006:Stokkermans Dubois J:a:case:of
2	1018-8665:2004:Gaber Y:secondary:lymphoedema:of
2	1018-4813:2008:Rezaie T:primary:non:syndromic
2	1015-8146:1998:Stoll C:lymphedema:combined:with
2	1010-5182:1996:Mishima K:three:cases:of
2	0969-0700:2014:Benbow M:safety:tolerability:and
2	0969-0700:1998:Jeffs E:management:of:chronic
2	0967-2109:2001:Bergan J:growing:the:vascular
2	0966-0461::Williams A:management:of:lymphoedema
2	0964-6906:2009:Downes M:vascular:defects:in
2	0964-6906:2005:Berry F:the:establishment:of
2	0964-6906:2003:Kriederman B:foxc:haploinsufficient:mice
2	0964-6906:2001:Finegold D:truncating:mutations:in
2	0964-5284:2008:Alem M:acupuncture:in:the
2	0964-5284:2005:Filshie J:acupuncture:and:self
2	0964-5284:2001:Filshie J:safety:aspects:of
2	0963-8172:1999:Melville A:management:of:gynaecological
2	0963-8172:1993:Romain K:advanced:cancer:aiming
2	0963-8172:1993:Rigge M:obtaining:the:views
2	0963-8172:1993:Corbett E:patients:awareness:of
2	0961-5423:2002:Williams A:a:randomized:controlled
2	0961-5423:1996:Williams A:a:year:review
2	0961-5423:1996:Suneson B:clinical:incidence:of
2	0961-5423:1996:Kirshbaum M:the:development:implementation
2	0961-5423:1995:Sitzia J:volume:measurement:in
2	0961-5423:1995:Preston N:new:strategies:for
2	0961-5423:1994:Badger C:pause:for:thought
2	0961-5423:1993:Woods M:patients:perceptions:of
2	0961-5423:1993:Woods M:a:hospital:based
2	0960-7692:2003:Lev Sagie A:prenatal:ultrasonographic:diagnosis
2	0959-8138:2006:Enoch S:non:surgical:and
2	0959-8138:2004:Swan M:surgical:management:of
2	0959-8138:2003:Tovey C:diagnosis:investigation:and
2	0959-8138:2003:Herxheimer A:relationships:between:the
2	0959-8138:2003:Brignall I:you:matter:to
2	0959-8138:2002:Bernard P:oral:pristinamycin:versus
2	0959-8138:2000:Yamey G:global:alliance:launches
2	0959-8138:2000:Shah J:postoperative:pressure:sores
2	0959-8138:2000:Mortimer P:swollen:lower:limb
2	0959-8138:2000:London N:ulcerated:lower:limb
2	0959-8138:2000:Gorman W:swollen:lower:limb
2	0959-8138:1999:Goodare H:involving:patients:in
2	0959-8138:1999:Dupuy A:risk:factors:for
2	0959-8138:1999:Baum M:contribution:of:randomised
2	0959-8138:1998:O Neill B:abc:of:palliative
2	0959-8138:1997:Regnard C:abc:of:palliative
2	0959-8138:1995:Spittle M:brachial:plexus:neuropathy
2	0959-8138:1994:Tirelli U:malignant:tumours:in
2	0959-8138:1994:Maguire P:abc:of:breast
2	0959-8138:1994:Bundred N:abc:of:breast
2	0959-8138:1993:Marsden P:obstructive:lymphatic:filariasis
2	0959-8138:1993:Casley Smith J:treatment:of:filarial
2	0959-8138:1992:Rubens R:management:of:early
2	0959-8138:1991:Varty K:what:happens:to
2	0959-8138:1991:Reilly D:abc:of:vascular
2	0959-8138:1991:O Dwyer P:axillary:dissection:in
2	0959-8138:1991:Kleijnen J:clinical:trials:of
2	0959-8138:1989:Kingston H:abc:of:clinical
2	0959-8138:1989:Green T:malignant:fibrous:histiocytoma
2	0959-8138:1989:Chambers M:necrosis:of:the
2	0959-8138:1988:Rigter H:euthanasia:across:the
2	0959-8049:2003:Rampaul R:incidence:of:clinically
2	0959-8049:2003:Pain S:is:physical:function
2	0959-8049:2001:Ververs J:risk:severity:and
2	0959-8049:2001:Levine A:clinical:aspects:and
2	0959-8049:1999:Mckinna F:lymphatic:relapse:in
2	0959-8049:1996:Renolleau C:isolated:axillary:recurrences
2	0959-8049:1994:Svensson W:increased:arterial:inflow
2	0959-8049:1994:Svensson W:colour:doppler:demonstrates
2	0959-4493:2004:Muller A:p:three:cases
2	0959-4493:2004:Bourdeau P:p:evaluation:of
2	0959-4493:2004:Bourdeau P:p:characteristics:of
2	0956-4624:2009:Talwar A:vulval:lymphoedema:following
2	0954-6820:2002:Usta M:a:family:with
2	0950-821X:1992:Haaverstad R:the:use:of
2	0950-821X:1992:Chant A:hypothesis:why:venous
2	0950-821X:1988:Lozano F:an:unusual:cause
2	0950-2688:2005:Oliver J:wound:infections:caused
2	0950-2688:1991:Sabesan S:the:dynamics:of
2	0945-053X:2001:Vikkula M:molecular:genetics:of
2	0941-4355:2016:Zecha J:low:level:laser
2	0941-4355:2002:Ashikaga T:use:of:complimentary
2	0941-4355:1995:Munstedt K:breast:forms:after
2	0939-7248:1995:Martinot Duquennoy V:congenital:annular:constricting
2	0936-6555:2000:Fernando I:the:role:of
2	0936-6555:1994:Fairlamb D:prophylactic:supraclavicular:fossa
2	0934-9723:2000:Woo P:cellulitis:complicating:lymphoedema
2	0931-184X:2002:Kvist P:evaluation:of:the
2	0931-041X:2001:Sombolos K:end:stage:renal
2	0930-1038:2002:Assouad J:the:cutaneo:lymph
2	0929-8266:1998:Maconi G:ultrasonographic:features:of
2	0929-8266:1998:Grainger A:the:ultrasound:appearances
2	0929-693X:1998:Erkan T:syndrome:de:hennekam
2	0926-9959:2003:Van De Scheur M:ano:genital:granulomatosis
2	0926-9959:2002:Kuku I:gemcitabine:induced:erysipeloid
2	0926-9959:2001:Atillasoy E:lymphoedema:associated:with
2	0926-9959:2000:Van Geest A:an:impressive:therapeutic
2	0926-9959:1998:Potouridou I:classic:kaposi:s
2	0926-9959:1997:Virgili A:lymphangioma:and:lymphangiectasis
2	0926-9959:1997:Virgili A:carcinoma:erysipeloides:of
2	0926-9959:1997:Verma K:erosive:lichen:planus
2	0926-9959:1997:Munn S:chromoblastomycosis:a:case
2	0926-9959:1997:Greaves M:flushing:causes:investigation
2	0925-5710:2004:Takahashi M:molecular:mechanisms:of
2	0923-7534:2007:Moseley A:a:systematic:review
2	0923-2494:1990:Root Bernstein R:non:hiv:immunosuppressive
2	0909-752X:2004:Wortsman X:real:time:spatial
2	0903-1936:2001:D Alessandro A:yellow:nail:syndrome
2	0903-1936:1999:Mogulkoc N:chylothorax:chylopericardium:and
2	0902-0063:2008:De Bartolomeis C:generalized:lymphedema:in
2	0885-3924:2009:Fu M:breast:cancer:survivors
2	0885-3924:1999:Andrykowski M:rheumatoid:symptoms:following
2	0885-3924:1990:Vecht C:arm:pain:in
2	0885-0666:1994:Mirvis S:trauma:radiology:part
2	0884-8734:2007:Zakaria S:breast:cancer:presenting
2	0884-8734:2006:Westrup J:risk:of:decline
2	0884-2175:1996:Miaskowski C:special:needs:related
2	0883-2897:1990:Kramer E:lymphoscintigraphy:radiopharmaceutical:selection
2	0832-610X:1998:Grange C:anaesthesia:in:a
2	0792-5077:2009:Satarasinghe R:lympidem:a:coumarin
2	0770-3198:1995:Sant S:lymphatic:obstruction:in
2	0770-3198:1994:Minari C:lymphoedema:of:the
2	0761-8425:2012:Letheulle J:le:syndrome:des
2	0749-5161:2000:Watanabe T:congenital:penoscrotal:lymphedema
2	0749-2081:1998:Joyce M:metastases:that:interfere
2	0748-7983:2003:Bilen B:epidermoid:carcinoma:arising
2	0748-7983:1999:Stotter A:breast:cancer:outcome
2	0748-7983:1999:Chadwick D:lymphoedema:subcutaneous:fibrosis
2	0748-7983:1988:Lowdell C:an:unusual:case
2	0743-684X:2008:Morihisa Y:objective:assessment:of
2	0743-684X:2005:Classen D:free:muscle:flap
2	0743-684X:2003:Koshima I:long:term:follow
2	0743-684X:2000:Koshima I:supermicrosurgical:lymphaticovenular:anastomosis
2	0743-684X:1989:Pho R:adipose:veno:lymphatic
2	0741-5214:1995:Muluk S:klippel:trenaunay:syndrome
2	0741-5214:1992:Pappas C:long:term:results
2	0741-5214:1989:Golueke P:lymphoscintigraphy:to:confirm
2	0741-5214:1989:Gloviczki P:noninvasive:evaluation:of
2	0741-5214:1988:Gloviczki P:microsurgical:lymphovenous:anastomosis
2	0741-5214:1986:Gloviczki P:the:natural:history
2	0738-1085:2003:Yamamoto Y:follow:up:study
2	0738-1085:2001:Campisi C:the:use:of
2	0738-1085:2001:Campisi C:long:term:results
2	0738-1085:1996:Tanaka Y:experience:of:a
2	0738-1085:1995:Campisi C:derivative:lymphatic:microsurgery
2	0738-1085:1994:Zhang F:the:greater:omentum
2	0738-1085:1994:Filippetti M:modern:therapeutic:approaches
2	0738-1085:1988:Pan Y:recent:microsurgical:advances
2	0738-1085:1985:Huang G:microlymphaticovenous:anastomosis:for
2	0738-081X:1995:Partsch H:assessment:of:abnormal
2	0738-081X:1995:Harwood C:causes:and:clinical
2	0738-081X:1995:Badger C:education:proposals:for
2	0738-081X:1994:Mallon E:lymphedema:and:wound
2	0736-8046:2011:Lucas M:congenital:lymphedema:with
2	0736-8046:2010:Samimi M:lymphatic:compression:by
2	0736-8046:2002:Samlaska C:congenital:lymphedema:and
2	0736-8046:1998:Larralde M:lymphedema:as:a
2	0736-8046:1998:Bielsa I:generalized:nevus:spilus
2	0733-8635:1999:Klein J:post:tumescent:liposuction
2	0733-8635:1990:Angelini G:occupational:traumatic:lymphedema
2	0732-8893:1992:Bean B:acute:lymphatic:filariasis
2	0732-183X:2009:Norman S:lymphedema:in:breast
2	0732-183X:2008:Ahmed R:lymphedema:and:quality
2	0732-183X:2003:Mckenzie D:effect:of:upper
2	0732-183X:2002:Kwan W:chronic:arm:morbidity
2	0720-048X:2006:Lohrmann C:indirect:magnetic:resonance
2	0720-048X:2000:Soler R:magnetic:resonance:imaging
2	0720-048X:1998:Cammarota T:current:uses:of
2	0540-889X:1985:Schneider F:changes:in:the
2	0425-1644:2006:De Cock H:lymphoscintigraphy:of:draught
2	0392-9590:2009:Gasbarro V:the:ceap:l
2	0392-9590:2008:Partsch H:indications:for:compression
2	0392-9590:2008:Lee B:supplemental:surgical:treatment
2	0392-9590:2007:Dimakakos E:interstitial:magnetic:resonance
2	0392-9590:2005:Saito T:impaired:ambulatory:venous
2	0392-9590:2000:Dimakakos P:e:kondoleon:the
2	0392-9590:1999:Witte C:diagnostic:and:interventional
2	0392-9590:1999:L Uchli S:fluorescence:microlymphography:of
2	0392-9590:1999:Gloviczki P:principles:of:surgical
2	0392-9590:1999:Casley Smith J:benzo:pyrones:in
2	0392-9590:1999:Campisi C:role:of:microsurgery
2	0392-9590:1999:Campisi C:lymphoedema:modern:diagnostic
2	0392-9590:1999:Berlin E:postmastectomy:lymphoedema:treatment
2	0392-9590:1996:Yasuhara H:a:study:of
2	0389-2328:1993:Takamura A:is:postoperative:radiotherapy
2	0385-5600:2004:Baskar L:development:and:evaluation
2	0368-2811:1999:Imoto S:initial:experience:with
2	0368-2811:1993:Ravi R:prophylactic:lymphadenectomy:vs
2	0368-2811:1984:Tsunematsu Y:a:clinicopathological:study
2	0364-2348:2005:Schindera S:stewart:treves:syndrome
2	0364-2348:2000:Nakazono T:angiosarcoma:associated:with
2	0364-2313:2004:Campisi C:microsurgical:techniques:for
2	0364-2313:1981:Baumeister R:experimental:basis:and
2	0364-2313:1979:O Brien B:microlymphaticovenous:and:resectional
2	0364-216X:1991:Apesos J:functional:applications:of
2	0363-9762:2002:Weiss M:post:therapeutic:lymphedema
2	0363-9762:2002:Habib G:acute:lymphedema:of
2	0363-9762:2002:Bhatnagar P:massive:hemangioma:or
2	0363-9762:2002:Bellini C:lymphoscintigraphic:evaluation:of
2	0363-9762:2000:Williams W:radionuclide:lymphangioscintigraphy:in
2	0363-9762:1996:Tsai S:nuclear:imaging:in
2	0363-9762:1989:Nawaz K:tc:m:serum
2	0363-9762:1989:Intenzo C:lymphedema:of:the
2	0363-9762:1986:Yeh S:lymphoscintigraphic:studies:of
2	0363-9762:1986:Ohtake E:lymphoscintigraphy:in:patients
2	0363-9762:1986:Nawaz K:dynamic:lymph:flow
2	0363-6135:2012:Mendez U:functional:recovery:of
2	0363-6135:2012:Mendez U:a:chronic:and
2	0363-6135:2008:Uzarski J:the:resolution:of
2	0363-5023:1993:Gschwind C:rheumatoid:lymphedema:a
2	0363-5023:1985:Louis D:the:upper:extremity
2	0363-5023:1980:Simmons B:the:clenched:fist
2	0363-5023:1977:Drake D:an:unusual:ring
2	0361-803X:2004:Deguzman A:mammographic:appearance:of
2	0361-803X:2002:Moshiri M:using:lymphoscintigraphy:to
2	0361-803X:1991:Kazerooni E:ct:appearance:of
2	0361-803X:1990:Cox J:periportal:lymphedema:in
2	0361-803X:1988:Koslin D:hepatic:perivascular:lymphedema
2	0360-3997:1985:Casley Smith J:importance:of:the
2	0360-3016:2001:Tinger A:effective:palliative:radiation
2	0360-3016:2000:Janni W:radiotherapy:of:the
2	0360-3016:1996:Touboul E:possibility:of:conservative
2	0360-3016:1993:Petereit D:inguinofemoral:radiation:of
2	0360-3016:1984:Pilepich M:treatment:related:morbidity
2	0344-0338:1986:Jellinek H:role:of:the
2	0343-8554:1988:Pfaff A:unilateral:secondary:postmastectomy
2	0343-8554:1984:Von Heyden D:cases:from:the
2	0343-8554:1983:Von Heyden D:cases:from:edema
2	0340-6997:1994:Al Nahhas A:reversible:findings:of
2	0340-6997:1987:Baulieu F:visualization:of:the
2	0340-6717:2005:Sholto Douglas Vernon C:lymphoedema:distichiasis:and
2	0340-6717:2001:Bell R:analysis:of:lymphoedema
2	0340-6717:1980:Pap Z:syndrome:of:lymphoedema
2	0340-6245:2007:Liersch R:lymphangiogenesis:in:development
2	0340-6245:2003:Lohela M:lymphangiogenic:growth:factors
2	0340-6199:2003:Chiappini E:selective:deficiency:of
2	0340-6199:1998:Bolt R:congenital:lymphoedema:of
2	0340-6199:1986:Smeltzer D:primary:lymphatic:dysplasia
2	0315-162X:1999:Salvarani C:distal:extremity:swelling
2	0315-162X:1997:Bardare M:idiopathic:limb:edema
2	0315-162X:1996:Fellows L:pasteurella:multocida:arthritis
2	0315-162X:1995:Kiely P:upper:limb:lymphatic
2	0315-162X:1994:Kiely P:upper:limb:lymphedema
2	0315-162X:1990:Salvarani C:upper:limb:lymphedema
2	0315-162X:1989:Athreya B:lymphedema:associated:with
2	0315-162X:1986:Wendt R:polyarticular:pigmented:villonodular
2	0309-0167:2000:Ruck P:multinucleated:stromal:cells
2	0309-0167:1991:Fletcher C:spindle:cell:haemangioendothelioma
2	0309-0167:1989:Zoltie N:spindle:cell:haemangioendothelioma
2	0307-7772:1976:Moran M:upper:respiratory:problems
2	0307-6938:2008:Nagasaka T:persistent:lymphoedema:in
2	0307-6938:2005:Pearson I:porokeratosis:in:association
2	0307-6938:1999:Azurdia R:chronic:lymphoedema:and
2	0307-6938:1996:Rongioletti F:mossy:leg:with
2	0307-6938:1993:Arroyo J:improvement:of:yellow
2	0307-6938:1991:O Driscoll J:chylous:reflux:into
2	0307-6938:1991:Dabski K:destructive:granuloma:annulare
2	0307-6938:1978:Somorin A:the:yellow:nail
2	0306-6800:1998:Avins A:can:unequal:be
2	0306-6800:1978:Twycross R:the:assessment:of
2	0306-3690:1965:Stewart I:pressure:bandages:and
2	0306-3674:1993:Zelikovski A:the:effects:of
2	0306-3674:1985:Casley Smith J:the:lymphatic:system
2	0306-3674:1979:Marley W:chronic:respiratory:failure
2	0306-3623:1996:Hoult J:pharmacological:and:biochemical
2	0304-3959:2000:Gottrup H:psychophysical:examination:in
2	0304-3959:1989:Vecht C:post:axillary:dissection
2	0303-6987:2011:Shon W:cutaneous:angiosarcoma:arising
2	0303-6987:2002:Kiyohara T:spindle:cell:angiosarcoma
2	0303-6987:2000:Fair K:lipedematous:alopecia:a
2	0303-6987:1999:Mu X:acquired:vulvar:lymphangioma
2	0302-766X:1988:Pabst R:regeneration:of:autotransplanted
2	0302-2838:2004:Okeke A:lymphoedema:in:urological

Manipulations en shell (Unix/Dilib)

HfdCat /applis/lorexplor/Wicri/Sante/explor/Lymphedema.storage/LymphedemaV1.20171104/Data/Main/Merge/Idat.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024

	Serveur d'exploration sur le lymphœdème - Merge (Accueil) Index « Idat.i » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur le lymphœdème - Merge (Accueil)Index « Idat.i » - tête de navigation

Index : Idat.i

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration sur le lymphœdème - Merge (Accueil)

Index « Idat.i » - tête de navigation